Literature DB >> 11498237

Gaucher's disease.

D Elstein1, A Abrahamov, I Hadas-Halpern, A Zimran.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498237     DOI: 10.1016/S0140-6736(01)05490-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Miglustat.

Authors:  Paul L McCormack; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Fever, pulmonary interstitial fibrosis, and hepatomegaly in a 15-year-old boy with Gaucher disease: a case report.

Authors:  Meng Yang
Journal:  J Med Case Rep       Date:  2018-10-21

3.  An ACE diagnosis.

Authors:  Omar Nasher; Anindya Gupta
Journal:  BMJ Case Rep       Date:  2013-02-14

4.  Cauda equina syndrome due to an intra-dural sacral cyst in type-1 Gaucher disease.

Authors:  Abderrahmane Hamlat; Stephan Saikali; Mohamed Lakehal; Michèle Pommereuil; Xavier Morandi
Journal:  Eur Spine J       Date:  2003-12-20       Impact factor: 3.134

5.  Apparent diffusion coefficient vale of the brain in patients with Gaucher's disease type II and type III.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nahed Abd El-Gaber; Ahmed Abdalla; Abeer Fathy; Ahmed Azab; Ashraf Abdel Rahman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

6.  A Rare Case of Hemoglobin E Hemoglobinopathy with Gaucher's Disease.

Authors:  Tathagata Chatterjee; Khushboo Dewan; P Ganguli; Satyaranjan Das; Ajay Sharma; A K Sahni; Pramod Nath
Journal:  Indian J Hematol Blood Transfus       Date:  2012-04-18       Impact factor: 0.900

Review 7.  Gaucher disease: pediatric concerns.

Authors:  Deborah Elstein; Aya Abrahamov; Altoon Dweck; Irith Hadas-Halpern; Ari Zimran
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Gaucher disease. Unusual presentation and mini-review.

Authors:  Tamer M Rizk; Rafiu O Ariganjoye; Gihad I Alsaeed
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

9.  Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report.

Authors:  Gaetano Giuffrida; Rita Lombardo; Ernesto Di Francesco; Laura Parrinello; Francesco Di Raimondo; Agata Fiumara
Journal:  J Med Case Rep       Date:  2016-11-08

10.  Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease.

Authors:  Aimee Donald; Chong Y Tan; Anupam Chakrapani; Derralyn A Hughes; Reena Sharma; Duncan Cole; Stanislav Bardins; Martin Gorges; Simon A Jones; Erich Schneider
Journal:  Orphanet J Rare Dis       Date:  2020-12-17       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.